Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Hepatocellular 46Liver Neoplasms 9Neoplasm Metastasis 4Leukemia, Myeloid, Acute 4Pancreatic Neoplasms 3Melanoma 3Carcinoma, Renal Cell 3Sarcoma 2Recurrence 2Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Breast Neoplasms 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Testicular Neoplasms 1Relapsed Pediatric Solid Tumor 1Portal Vein Tumor Thrombus 1Neoplasms, Glandular and Epithelial 1Neoplasms, Germ Cell and Embryonal 1Neoplasms by Site 1Neoplasms by Histologic Type 1Mesothelioma 1Lung Neoplasms 1Liver Diseases 1Leukemia, Monocytic, Acute 1Kidney Neoplasms 1Hemangiosarcoma 1HCC 1Gastrointestinal Neoplasms 1

Interventions

Doxorubicin 2genexol-PM 1brostallicin 1avelumab 1Urination 1Temozolomide 1Surveys and Questionnaires 1Sorafenib 1Radiotherapy 1Propranolol 1Paclitaxel 1Neoadjuvant Therapy 1Molecular Diagnostic Techniques 1Microarray Analysis 1Interviews as Topic 1Ifosfamide 1Chemotherapy, Adjuvant 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Hemangiosarcoma × Sorafenib × Clear all
NCT00874874 2009-12-24

Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2 Unknown
96 enrolled
Sarcoma

Hemangiosarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡